Carolyn Ho
Carolyn Ho is an expert in Cardiology at Brigham and Women's Hospital (United States). As of October 2026, ScienceLeadR ranks Carolyn Ho in the top 1% of experts worldwide for Aortic Valve Disease and Cardiomyopathies. Carolyn Ho has authored 105 publications, the most recent in 2026, and is an investigator in 6 clinical trials, 3 of them ongoing. SLR score: 541 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Genetics - Public Health - Medical Imaging
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2006 - 2026
Number : 105
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Natural History of Asymptomatic Phenotypically Mild HCM: Insights From the SHaRe Registry. PMID 42417692 — registries, natural history, heart failure, atrial fibrillation, cardiology, signs and symptoms, therapeutics, history | J Am Coll Cardiol | 2026 | 5 |
| Reply: Trajectory-Based Myocardial Remodeling and MACE Risk in Phenotypically Mild HCM. PMID 42904618 — cardiology | J Am Coll Cardiol | 2026 | 0 |
| Genotype and arrhythmic risk in dilated cardiomyopathy. PMID 42864989 — cardiomyopathy, dilated, genes, arrhythmias, cardiac, cardiology, sex, genotype, diagnosis, cardiomyopathies | Eur Heart J Top journal | 2026 | 1 |
| Body Mass Index, Valsartan, and Myocardial Remodeling in Early-Stage Hypertrophic Cardiomyopathy: A Secondary Analysis of the Randomized VANISH Trial. PMID 42858009 — valsartan, heart diseases, body mass index, cardiomyopathy, hypertrophic, angiotensin receptor antagonists, obesity, cardiomyopathies | J Am Heart Assoc | 2026 | 0 |
| Clinical Characteristics and Outcomes of Hypertrophic Cardiomyopathy Associated With Thin Filament Variants: Insights From the SHaRe Registry. PMID 42779549 — registries, genes, genetics, amino acids, heart, arrhythmias, cardiac, atrial fibrillation, cardiomyopathy, hypertrophic, odds ratio, diagnosis, transplants, cardiomyopathies | Circ Genom Precis Med | 2026 | 0 |
Clinical Studies 6
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Ongoing Clinical Trials
3 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| HCMR Re Imaging Study NCT07054073 — muscles, heart, cardiomyopathy, hypertrophic, myocardium, cardiomyopathies | N/A | Recruiting | 2026 |
| A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non Obstructive Hypertrophic Cardiomyopathy (nHCM) NCT06081894 — safety, multiple chronic conditions, tablets, cardiomyopathy, hypertrophic, cardiomyopathies | Phase 3 | Active not recruiting | 2023 |
| A Prospective Registry Study to Assess Real world Patient Characteristics Treatment Patterns and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive HCM) NCT05489705 — registries, disopyramide, safety, calcium channel blockers, heart failure, heart, cardiomyopathy, hypertrophic, calcium channels, calcium, therapeutics, cardiomyopathies | N/A | Recruiting | 2022 |
LeadR Networks
Main global connection map